Repositioning Candidate Details

Candidate ID: R0011
Source ID: DB00029
Source Type: approved
Compound Type: biotech
Compound Name: Anistreplase
Synonyms: Anisoylated plasminogen streptokinase activator complex; Anistreplase; APSAC
Molecular Formula: --
SMILES: --
DrugBank Description: Human tissue plasminogen activator, purified, glycosylated, 527 residues purified from CHO cells. Eminase is a lyophilized (freeze-dried) formulation of anistreplase, the p-anisoyl derivative of the primary Lys-plasminogen-streptokinase activator complex (a complex of Lys-plasminogen and streptokinase). A p-anisoyl group is chemically conjugated to a complex of bacterial-derived streptokinase and human Plasma-derived Lys-plasminogen proteins.
CAS Number: 81669-57-0
Molecular Weight:
DrugBank Indication: For lysis of acute pulmonary emboli, intracoronary emboli and management of myocardial infarction
DrugBank Pharmacology: Anistreplase cleaves the Arg/Val bond in plasminogen to form plasmin. Plasmin in turn degrades the fibrin matrix of the thrombus, thereby exerting its thrombolytic action. This helps eliminate blood clots or arterial blockages that cause myocardial infarction.
DrugBank MoA: Anistreplase cleaves the Arg/Val bond in plasminogen to form plasmin. This in turn leads to the degradation of blood clots.
Targets: Plasminogen activator; Fibrinogen alpha chain; Plasminogen activator inhibitor 1
Inclusion Criteria: Indication associated